Table 2. Absolute risk and unadjusted incidence rates for primary and secondary outcomes for both cohorts.
COVID-19 cohort | Influenza cohort | |||
---|---|---|---|---|
Absolute risk, N (%) | Incidence rates (per person-year) | Absolute risk, N (%) | Incidence rates (per person-year) | |
Primary Endpoints (Hospital Discharge ICD-10-CM Diagnosis) | ||||
Arterial thrombosis (combined) | 7,121 (1.7) | 0.11 | 3,035 (0.88) | 0.04 |
Venous thromboembolism (combined) | 4,278 (1) | 0.06 | 1,524 (0.44) | 0.02 |
Secondary Endpoints (ED or hospital discharge ICD-10-CM diagnosis) | ||||
Acute MI | 4,094 (0.98) | 0.06 | 2,008 (0.58) | 0.03 |
Acute ischemic or embolic stroke | 3,486 (0.83) | 0.05 | 1,217 (0.35) | 0.02 |
Acute upper/lower deep venous thrombosis | 2,455 (0.59) | 0.04 | 959 (0.28) | 0.01 |
Acute pulmonary embolism | 2,315 (0.55) | 0.03 | 772 (0.22) | 0.01 |
Expanded arterial thrombosis (combined) | 14,462 (3.5) | 0.22 | 7,609 (2.2) | 0.10 |
Expanded venous thromboembolism (combined) | 4,519 (1.1) | 0.07 | 1,640 (0.47) | 0.02 |
Abbreviations: ICD-10-CM—international classification of diseases, 10th revision; ED—emergency department; MI—myocardial infarction